Delivery Order SPE2DB24D9223-SPE2DB25FKEAA

Award Date 1/8/25
Potential Completion Date 1/30/25
Potential Value $6.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,729.76, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract covers the procurement of KCENTRA 500UNIT 1S, a pharmaceutical product, with a period of performance through August 30, 2024. The contract has no set-aside designation. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,919.04 firm fixed-price award is for the delivery of KCENTRA 500 unit vials, a prescription medication. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for the delivery of 1,000 unit vials of the biologic medication KCENTRA. The contract has a firm fixed-price, delivery order type, with a ceiling value of $58,453.12 and a period of performance through May 13, 2024. The contract is not associated with a set-aside...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, provides for the delivery of KCENTRA 1,000 unit vials to the Defense Logistics Agency (DLA). The $17,297.60 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical...
This contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $20,592.96, is for the delivery of 1,000 unit vials of the drug KCENTRA. The contract is a firm fixed-price delivery order, with an ultimate completion date of June 17, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,648.80 firm fixed-price delivery order is for the supply of 4,565,783,998 units of the drug KCENTRA 500 with an ultimate completion date of October 2, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of KCENTRA 500 UNIT VIALS to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The single-award indefinite delivery contract (IDC) valued at up to $499,999,999 allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,116.07 firm fixed-price delivery order is for the provision of 1,000 unit vials of the pharmaceutical drug Kcentra. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC,...
This federal contract award, with an ID of SPE2DB20D9331|SPE2DB23FL0P9, was issued by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $41,420.70 firm fixed-price delivery order is for the supply of 4559880956 units of the pharmaceutical product KCENTRA 500 UNIT VIALS. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,714.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the specialty pharmaceutical product Kcentra. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to...
  • SPE2DB24D9223
    Indefinite Delivery Contract
  • SPE2DB24D9223-SPE2DB25FKEAA
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,639.36 firm fixed-price delivery order is for 1,000 unit vials of the medication KCENTRA, with a period of performance through January 30, 2025.

DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.

This contract award does not have a set-aside designation, allowing DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 4/9/25, 10:45 AM